Alfuzosin - CAS 81403-80-7
Catalog number: 81403-80-7
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C19H27N5O4
Molecular Weight:
389.45
COA:
Inquire
Targets:
Adrenergic Receptor
Description:
Alfuzosin is a pharmaceutical drug of the alpha-1 blocker class. It works by relaxing the muscles in the prostate and bladder neck. It is used to treat benign prostatic hyperplasia (BPH). It offers an alternative to prostatectomy in patients who require surgery but are unfit for this treatment, and in patients requiring symptomatic relief while awaiting surgery. It is marketed in the United States by Sanofi Aventis under the brand name Uroxatral. It was approved by the FDA for treatment of BPH in June 2003. It has been approved the listing.
Purity:
99%
Appearance:
Solid powder
Synonyms:
Alfuzosina;Alfuzosine;Xatral;2-Furancarboxamide,N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-;N-[3-[N-(4-Amino-6,7-dimethoxyquinazolin-2-yl)-N-(methyl)amino]propyl]tetrahydrofuran-2-carboxamide;SL 77499;Alfuzosinum
Solubility:
DMSO 85 mg/mL (199 mM); Water 85 mg/mL (199 mM)
Storage:
-20°C Freezer
MSDS:
Inquire
Application:
Alfuzosin is used to treat benign prostatic hyperplasia (BPH).
Quality Standard:
In-house standard
Shelf Life:
2 month in rt, long time
Quantity:
Grams to Kilograms
Melting Point:
178-180 °C
Density:
1.272±0.06 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
InChIKey:
WNMJYKCGWZFFKR-UHFFFAOYSA-N
InChI:
InChI=1S/C19H27N5O4/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23)
Canonical SMILES:
CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC
Current Developer:
Alfuzosin is marketed in the United States by Sanofi Aventis under the brand name Uroxatral. It was approved by the FDA for treatment of BPH in June 2003. It has been approved the listing.
1.Assessment of column selection systems using Partial Least Squares.
Žuvela P1, Liu JJ2, Plenis A3, Bączek T3. J Chromatogr A. 2015 Nov 13;1420:74-82. doi: 10.1016/j.chroma.2015.09.085. Epub 2015 Oct 1.
Column selection systems based on calculation of a scalar measure based on Euclidean distance between chromatographic columns, suffer from the same issue. For diverse values of their parameters, identical or near-identical values can be calculated. Proper use of chemometric methods can not only provide a remedy, but also reveal underlying correlation between them. In this work, parameters of a well-established column selection system (CSS) developed at Katholieke Universiteit Leuven (KUL CSS) have been directly correlated to parameters of selectivity (retention time, resolution, and peak/valley ratio) toward pharmaceuticals, by employing Partial Least Squares (PLS). Two case studies were evaluated, separation of alfuzosin, lamotrigine, and their impurities, respectively. Within them, comprehensive correlation structure was revealed, which was thoroughly interpreted, confirming a causal relationship between KUL parameters and parameters of column performance.
2.Formulation and evaluation of gastroretentive controlled release tablets of alfuzosin hydrochloride.
Rudraswamy-Math NR1, Gupta VR1. Pak J Pharm Sci. 2015 Nov;28(6):2147-52.
Alfuzosin hydrochloride is a novel drug used in the treatment of urinary incontinency. The purpose of this research was to develop controlled release floating matrix formulations of Alfuzosin HCl. Floating matrix tablets of Alfuzosin HCl were prepared using hydroxypropyl methylcellulose (HPMC), Polyethylene oxide (PEO), Carbopol 971P NF polymer (Direct compressible) and Blend of Polyvinyl Acetate and Povidone 30 (80:19:1(0.8% sodium laury sulfate and 0.2% silica)). Combination of citric acid and sodium bicarbonate were also used as gas forming agent. Matrix formulations were prepared by direct compression method and evaluated for floating, in vitro drug release profile and swelling characteristics. The mechanism of drug release was found to follow non-Fickian or anomalous type. The data obtained from the invitro release studies demonstrated that the floating matrix tablets containing HPMC 100K CR (controlled-release) and carbopol along with sodium CMC were found to sustain the release of drug over a period of 12 hours.
3.Temperature influencing permeation pattern of alfuzosin: an investigation using DoE.
Pattnaik S1, Swain K2, Rao JV2, Varun T2, Mallick S3. Medicina (Kaunas). 2015;51(4):253-61. doi: 10.1016/j.medici.2015.07.002. Epub 2015 Jul 30.
BACKGROUND AND OBJECTIVE: There has been relatively little investigation of the effect of temperature on skin permeation compared to other methods of penetration enhancement. A principal physicochemical factor which controls the passive diffusion of a solute from a vehicle into the skin arises from the skin temperature. The aim of this ex vivo study was to probe into the effect of heat on transdermal absorption of alfuzosin hydrochloride from ethyl cellulose-polyvinyl pyrrolidone (EC-PVP) based transdermal systems.
4.Relative cytotoxic potencies and cell death mechanisms of α1 -adrenoceptor antagonists in prostate cancer cell lines.
Forbes A1, Anoopkumar-Dukie S2, Chess-Williams R1, McDermott C1. Prostate. 2016 Feb 16. doi: 10.1002/pros.23167. [Epub ahead of print]
BACKGROUND: Some α1 -adrenoceptor antagonists possess anti-cancer actions that are independent of α1 -adrenoceptors and the aim of these studies was to assess the relative cytotoxic potencies of α1 -adrenoceptor antagonists and the mechanisms involved in these actions.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Adrenergic Receptor Products


CAS 3811-25-4 Clorprenaline

Clorprenaline
(CAS: 3811-25-4)

Clorprenaline is a beta-adrenergic receptor agonist.

CAS 54765-26-3 Lerimazoline

Lerimazoline
(CAS: 54765-26-3)

Lerimazoline is an α-adrenergic receptor agonist. It inhibits secretion of nasal mucus. It causes hypertension. It is common used in the form of hydrochloride.

CAS 146-48-5 Yohimbine

Yohimbine
(CAS: 146-48-5)

Yohimbine, an indolalkylamine alkaloid, blocks presynaptic alpha-2 adrenergic receptors. IC50= 0.6 μM Ki: 1.05 nM, alphaα2Areceptor

CAS 498-45-3 Scopine

Scopine
(CAS: 498-45-3)

Scopine is the metabolite of anisodine, which is a α1-adrenergic receptor agonist and used in the treatment of acute circulatory shock.

CAS 51-42-3 Epinephrine Bitartrate

Epinephrine Bitartrate
(CAS: 51-42-3)

Epinephrine Bitartrate is an alpha- and beta-adrenergic receptor stimulator. It can be used for the treatment of asthma and cardiac failure via stimulating the ...

CAS 64208-32-8 CGP 12177 hydrochloride

CGP 12177 hydrochloride
(CAS: 64208-32-8)

CGP 12177 hydrochloride is a partial agonist of β3-adrenoceptors, and also an antagonist of β1- and β2-adrenoceptors (Ki = 0.9, 4 and 88 nM for β1, β2 and β3 re...

Phenylethanolamine A
(CAS: 1346746-81-3)

Phenylethanolamine A is a novel beta-agonist naturally occuring in animal species.

CAS 41937-02-4 Brombuterol

Brombuterol
(CAS: 41937-02-4)

Brombuterol is found to be a novel β-adrenergic agonist that can increase the meat-to-fat ratio but it is banned in animal feeds.

Chemical Structure

CAS 81403-80-7 Alfuzosin

Quick Inquiry

Verification code

Featured Items